Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic rosuvastatin 20 mg vs reference in healthy Thai volunteers (fasting)
TCTR20170614004Phase 1Not yet recruiting
- Sponsor
- Getz Pharma
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin in hypercholesterolemia (2 arms), sponsored by Getz Pharma. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20170614004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170614004.